Malnutrition, Inflammation, and Lipids in a Cohort of Dialysis Patients

References

• . Tsirpanlis G, Boufidou F, Zoga M, . Low cholesterol along with inflammation predicts morbidity and mortality in hemodialysis patients. Hemodial Int. 2009;13(2):197–204
   PubMed Web of Science ®Google Scholar
• . Chavalitdhamrong D, Danovitch GM, Bunnapradist S. Is there a reversal of reverse epidemiology in renal transplant recipients? Semin Dial. 2007;20(6):544–548
   PubMed Web of Science ®Google Scholar
• . Chmielewski M, Carrero JJ, Nordfors L, Lindholm B, Stenvinkel P. Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach. J Nephrol. 2008;21(5):635–644
   PubMed Web of Science ®Google Scholar
• . Dungan KM, Guster T, DeWalt, Buse JB. A comparison of lipid and lipoprotein measurement in the fasting and nonfasting states in patients with type 2 diabetes. Curr Med Res Opin. 2007;23(11):2689–2695
   PubMed Web of Science ®Google Scholar
• . Trivedi H, Xiang Q, Klein JP. Risk factors for non-fatal myocardial infarction and cardiac death in incident dialysis patients. Nephrol Dial Transplant. 2009;24(1):258–266
   PubMed Web of Science ®Google Scholar
• . Bowden RG, Griggs J, Wilson RL, Gentile M. Cholesterol values are poor markers of disease risk in a chronic disease population. Clin Lipid. 2009;4(5):545–551
   Web of Science ®Google Scholar
• . Diepeveen SH, Wetzels JF, Bilo HJ, van Tits LG, Stalenhoef AF. Cholesterol in end-stage renal disease: the good, the bad or the ugly? Neth J Med. 2008;66(2):53–61
   PubMed Web of Science ®Google Scholar
• . van der Harst P, Voors AA, van Gils WH, Böhm M, van Veldhuisen DJ. Statins in the treatment of chronic heart failure: biological and clinical considerations. Cardiovasc Res. 2006;71(3):443–454
   PubMed Web of Science ®Google Scholar
• . Kovesdy CP, Anderson JE. Reverse epidemiology in patients with chronic kidney disease who are not yet on dialysis. Semin Dial. 2007;20(6):566–569
   PubMed Web of Science ®Google Scholar
• . Kalantar-Zadeh K. Recent advances in understanding the malnutrition-inflammation-cachexia syndrome in chronic kidney disease patients: what is next? Semin Dial. 2005;18(5):365–369
   PubMed Web of Science ®Google Scholar
• . Kalantar-Zadeh K, Kopple JD. Obesity paradox in patients on maintenance dialysis. Contrib Nephrol. 2006;151:57–69
   PubMed Web of Science ®Google Scholar
• . Otvos J, Jeyarajah E, Cromwell W. Measurement issues related to lipoprotein heterogeneity. Am J Cardiol. 2002;90(8A):22i–29i
   PubMed Web of Science ®Google Scholar
• . Pearson TA, Mensah GA, Alexander RW, ; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499–511
   PubMed Web of Science ®Google Scholar
• . National Institutes of Health. Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults-Third Report. Washington, DC: US Government Printing Office; 2002
   Google Scholar
• . Mora S. Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use. Circulation. 2009;119(17):2396–2404
   PubMed Web of Science ®Google Scholar
• . Cromwell WC, Otvos JD. Low-density lipoprotein particle number and risk for cardiovascular disease. Curr Atheroscler Rep. 2004;6(5):381–387
   PubMedGoogle Scholar
• . Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ; Pittsburgh Epidemiology of Diabetes Complications Study.Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia. 2003;46(5):674–682
   PubMed Web of Science ®Google Scholar
• . Liu Y, Coresh J, Eustace J. Association between cholesterol level and mortality in dialysis patients role of inflammation and malnutrition. JAMA. 2004;291(4):451–459
   PubMed Web of Science ®Google Scholar
• . Venzin RM, Kamber N, Keller WC, Suter PM, Reinhart WH. How important is malnutrition? A prospective study in internal medicine. Eur J Clin Nutr. 2009;63(3):430–436
   PubMed Web of Science ®Google Scholar
• . Power A, Duncan N, Goodlad C. Advances and innovations in dialysis in the 21st century. Postgrad Med J. 2009;85(1000):102–107
   PubMed Web of Science ®Google Scholar
• . Nurmohamed SA, Nubé MJ. Reverse epidemiology: paradoxical observations in haemodialysis patients. Neth J Med. 2005;63(10):376–381
   PubMed Web of Science ®Google Scholar
• . Marcovecchio ML, Dalton RN, Prevost AT, . Prevalence of abnormal lipid profiles and the relationship with the development of microalbuminuria in adolescents with type I diabetes. Diabetes Care. 2009;32(4):658–663
   PubMed Web of Science ®Google Scholar
• . Cano NJ, Miolane-Debouit M, Léger J, Heng AE. Assessment of body protein: energy status in chronic kidney disease. Semin Nephrol. 2009;29(1):59–66
   PubMed Web of Science ®Google Scholar
• . Balakrishnan VS, Rao M. Genetics and reverse epidemiology among patients on chronic hemodialysis. Semin Dial. 2007;20(6):570–576
   PubMed Web of Science ®Google Scholar
• . Porazko T, Kuzniar J, Kusztal M, . IL-18 is involved in vascular injury in end-stage renal disease patients. Nephrol Dial Transplant. 2009;24(2):589–596
   PubMed Web of Science ®Google Scholar
• . Bowden RG, Hebert S, Wilson R, Gentile M, Lanning B. Comparison of lipid measures and risk stratification among end-stage renal disease patients. J Nephrol. 2007;20(2):212–218
   PubMed Web of Science ®Google Scholar
• . Shelmadine B, Bowden RG, Wilson RL, Beavers D, Hartman J. The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end stage renal disease patients: a pilot study. Anadolu Kardiyol Derg. 2009;9(5):385–389
   PubMedGoogle Scholar
• . Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C; German Diabetes and Dialysis Study Investigators.Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus. Am J Kidney Dis. 2009;54(5):902–911
   PubMed Web of Science ®Google Scholar